Cumberland Pharmaceuticals Valuation
| CPIX Stock | USD 3.22 0.49 13.21% |
At this time, the firm appears to be undervalued. Cumberland Pharmaceuticals shows a prevailing Real Value of $4.52 per share. The current price of the firm is $3.22. Our model approximates the value of Cumberland Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -0.12, profit margin of (0.08) %, and Current Valuation of 46.2 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Cumberland Pharmaceuticals' price fluctuation is very risky at this time. Calculation of the real value of Cumberland Pharmaceuticals is based on 3 months time horizon. Increasing Cumberland Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cumberland Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cumberland Stock. However, Cumberland Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.22 | Real 4.52 | Hype 3.22 | Naive 4.31 |
The intrinsic value of Cumberland Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cumberland Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cumberland Pharmaceuticals helps investors to forecast how Cumberland stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cumberland Pharmaceuticals more accurately as focusing exclusively on Cumberland Pharmaceuticals' fundamentals will not take into account other important factors: Cumberland Pharmaceuticals Total Value Analysis
Cumberland Pharmaceuticals is currently forecasted to have valuation of 46.2 M with market capitalization of 48.17 M, debt of 20.57 M, and cash on hands of 18.22 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cumberland Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
46.2 M | 48.17 M | 20.57 M | 18.22 M |
Cumberland Pharmaceuticals Investor Information
About 42.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cumberland Pharmaceuticals recorded a loss per share of 0.24. The entity last dividend was issued on the 29th of October 2010. The firm had 2:1 split on the 6th of July 2007. Based on the key indicators related to Cumberland Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Cumberland Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Cumberland Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cumberland Pharmaceuticals has an asset utilization ratio of 50.1 percent. This suggests that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Cumberland Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Cumberland Pharmaceuticals Ownership Allocation
The market capitalization of Cumberland Pharmaceuticals is $48.17 Million. Cumberland Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Cumberland Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.44 T) with profit before overhead, payroll, taxes, and interest of 34.65 M.About Cumberland Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Cumberland Pharmaceuticals. We calculate exposure to Cumberland Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cumberland Pharmaceuticals's related companies.Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Cumberland Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.1 M |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.